The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zoladex 3.6 mg Implant

3.6 Base Milligrams Implant

AstraZeneca ABPA1019/027/001

Main Information

Trade NameZoladex 3.6 mg Implant
Active SubstancesGoserelin acetate
Strength3.6 Base Milligrams
Dosage FormImplant
Licence HolderAstraZeneca AB
Licence NumberPA1019/027/001

Group Information

ATC CodeL02AE Gonadotropin releasing hormone analogues
L02AE03 goserelin


Licence Issued02/02/1999
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back